FRONTIER CAPITAL MANAGEMENT CO LLC – Supernus Pharmaceuticals, Inc. Transaction History
FRONTIER CAPITAL MANAGEMENT CO LLC portfolio value:
$23.79M
portfolio value
FRONTIER CAPITAL MANAGEMENT CO LLC quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +14.02% | 86.43K shares | 5.96M | $33.85 | 702.80K |
Q2 2022 | share | Decrease | -5.37% | -34.98K shares | -3.22M | $28.92 | 616.37K |
Q1 2022 | share | Increase | +5.45% | 33.65K shares | 3.04M | $32.32 | 651.35K |
Q4 2021 | share | Increase | +6.67% | 38.62K shares | 2.56M | $30.03 | 617.70K |
Q3 2021 | share | Decrease | -29.10% | -237.65K shares | -9.70M | $26.67 | 579.07K |
Q2 2021 | share | Increase | +6.13% | 47.20K shares | 5.00M | $30.79 | 816.73K |
Q1 2021 | share | Increase | 0.00% | 769.52K shares | 20.14M | $26.18 | 769.52K |